4//SEC Filing
Smith Alan K. 4
Accession 0001705246-20-000002
CIK 0001358403other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:00 PM ET
Size
13.9 KB
Accession
0001705246-20-000002
Insider Transaction Report
Form 4
Smith Alan K.
EVP, Technical Oprations
Transactions
- Tax Payment
Common Stock
2020-01-02$1.51/sh−883$1,333→ 5,982 total - Exercise/Conversion
Restricted Stock Units
2020-01-03−1,563→ 1,562 total→ Common Stock (1,563 underlying) - Exercise/Conversion
Common Stock
2020-01-02+2,344→ 6,865 total - Exercise/Conversion
Common Stock
2020-01-03+1,563→ 7,545 total - Tax Payment
Common Stock
2020-01-03$1.40/sh−589$825→ 6,956 total - Exercise/Conversion
Restricted Stock Units
2020-01-02−2,344→ 4,687 total→ Common Stock (2,344 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 9,375 shares.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 6,250 shares.
- [F4]On January 2, 2018, the reporting person was granted 9,375 RSUs, of which 2,344 vested on January 2, 2020. The RSUs vest in four annual installments beginning January 2, 2019.
- [F5]On January 3, 2017, the reporting person was granted 6,250 RSUs, of which 1,563 vested on January 3, 2020. The RSUs vest in four annual installments beginning January 3, 2018.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001705246
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:00 PM ET
- Size
- 13.9 KB